 Emily DeBoer
Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 9 | 2026 | 525 | 3.800 |
Why?
| | Deglutition Disorders | 8 | 2026 | 154 | 2.540 |
Why?
| | Bronchiectasis | 5 | 2024 | 115 | 2.250 |
Why?
| | Esophageal Atresia | 4 | 2022 | 32 | 1.980 |
Why?
| | Tracheoesophageal Fistula | 4 | 2022 | 40 | 1.960 |
Why?
| | Lung Diseases, Interstitial | 7 | 2024 | 664 | 1.800 |
Why?
| | Bronchoscopy | 8 | 2021 | 227 | 1.540 |
Why?
| | Cystic Fibrosis | 7 | 2022 | 1161 | 1.310 |
Why?
| | Lung Diseases | 3 | 2025 | 780 | 1.280 |
Why?
| | Lung | 13 | 2025 | 4106 | 1.220 |
Why?
| | Child | 40 | 2026 | 22707 | 1.210 |
Why?
| | Tomography, X-Ray Computed | 10 | 2025 | 2769 | 1.090 |
Why?
| | Oscillometry | 2 | 2025 | 35 | 1.040 |
Why?
| | Computer Simulation | 3 | 2021 | 1003 | 0.980 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 638 | 0.970 |
Why?
| | Idiopathic Pulmonary Fibrosis | 5 | 2026 | 692 | 0.940 |
Why?
| | Respiratory System Abnormalities | 1 | 2025 | 18 | 0.910 |
Why?
| | Proteomics | 5 | 2023 | 1188 | 0.900 |
Why?
| | Airway Resistance | 2 | 2025 | 38 | 0.900 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2025 | 302 | 0.830 |
Why?
| | Child, Preschool | 20 | 2026 | 11853 | 0.810 |
Why?
| | Delphi Technique | 2 | 2024 | 332 | 0.760 |
Why?
| | Airway Obstruction | 2 | 2021 | 153 | 0.750 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 147 | 0.750 |
Why?
| | Resilience, Psychological | 1 | 2024 | 149 | 0.720 |
Why?
| | Respiratory Tract Infections | 2 | 2026 | 396 | 0.720 |
Why?
| | Respiration Disorders | 2 | 2020 | 78 | 0.690 |
Why?
| | Hydrodynamics | 1 | 2021 | 50 | 0.670 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 45 | 0.660 |
Why?
| | Protein C | 1 | 2021 | 54 | 0.660 |
Why?
| | Infant | 15 | 2026 | 10077 | 0.650 |
Why?
| | Burnout, Professional | 2 | 2024 | 488 | 0.640 |
Why?
| | Deglutition | 5 | 2025 | 73 | 0.630 |
Why?
| | Heart Diseases | 1 | 2023 | 341 | 0.610 |
Why?
| | Humans | 55 | 2026 | 145474 | 0.600 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 468 | 0.600 |
Why?
| | Intellectual Disability | 1 | 2021 | 179 | 0.600 |
Why?
| | Gastrointestinal Diseases | 2 | 2018 | 221 | 0.590 |
Why?
| | Tomography | 2 | 2021 | 45 | 0.580 |
Why?
| | Models, Anatomic | 2 | 2020 | 87 | 0.570 |
Why?
| | Air | 1 | 2018 | 44 | 0.550 |
Why?
| | Retrospective Studies | 17 | 2026 | 17291 | 0.540 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.540 |
Why?
| | Health Status | 1 | 2023 | 832 | 0.540 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 87 | 0.530 |
Why?
| | Respiration | 1 | 2018 | 206 | 0.520 |
Why?
| | Trachea | 4 | 2020 | 258 | 0.510 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 314 | 0.490 |
Why?
| | Hospitalization | 1 | 2026 | 2460 | 0.460 |
Why?
| | Adolescent | 18 | 2026 | 22529 | 0.450 |
Why?
| | Tracheomalacia | 3 | 2020 | 17 | 0.440 |
Why?
| | Pneumonia | 1 | 2021 | 636 | 0.440 |
Why?
| | Male | 27 | 2026 | 72842 | 0.430 |
Why?
| | Female | 27 | 2026 | 78844 | 0.410 |
Why?
| | Bronchi | 1 | 2015 | 263 | 0.410 |
Why?
| | Gastroesophageal Reflux | 2 | 2015 | 237 | 0.400 |
Why?
| | Models, Biological | 1 | 2021 | 1764 | 0.400 |
Why?
| | Automation | 1 | 2014 | 104 | 0.400 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 779 | 0.400 |
Why?
| | Respiratory Tract Diseases | 3 | 2019 | 175 | 0.380 |
Why?
| | Indoles | 3 | 2026 | 507 | 0.370 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 5 | 0.360 |
Why?
| | Young Adult | 8 | 2026 | 14218 | 0.350 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1957 | 0.350 |
Why?
| | Models, Statistical | 1 | 2015 | 671 | 0.340 |
Why?
| | Esophagoscopy | 3 | 2019 | 223 | 0.340 |
Why?
| | Twins, Monozygotic | 1 | 2012 | 133 | 0.340 |
Why?
| | Diseases in Twins | 1 | 2012 | 116 | 0.340 |
Why?
| | Family Health | 1 | 2012 | 191 | 0.330 |
Why?
| | Referral and Consultation | 2 | 2026 | 867 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3904 | 0.320 |
Why?
| | Patient Readmission | 1 | 2016 | 769 | 0.310 |
Why?
| | Electric Impedance | 3 | 2021 | 108 | 0.310 |
Why?
| | Asthma | 1 | 2021 | 1797 | 0.300 |
Why?
| | Neuroendocrine Cells | 2 | 2019 | 33 | 0.290 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 331 | 0.280 |
Why?
| | Respiratory Function Tests | 2 | 2025 | 544 | 0.280 |
Why?
| | Thoracoscopy | 2 | 2019 | 60 | 0.280 |
Why?
| | Electronic Health Records | 1 | 2016 | 1196 | 0.260 |
Why?
| | Internship and Residency | 1 | 2018 | 1267 | 0.260 |
Why?
| | Case-Control Studies | 3 | 2019 | 3623 | 0.240 |
Why?
| | Patient Care Team | 2 | 2024 | 696 | 0.230 |
Why?
| | Prospective Studies | 4 | 2025 | 8057 | 0.220 |
Why?
| | Albuterol | 1 | 2025 | 76 | 0.220 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 910 | 0.210 |
Why?
| | Polysomnography | 1 | 2025 | 239 | 0.210 |
Why?
| | Respiratory Rate | 1 | 2023 | 23 | 0.200 |
Why?
| | Infant, Newborn | 5 | 2025 | 6447 | 0.190 |
Why?
| | Postoperative Complications | 1 | 2016 | 2970 | 0.190 |
Why?
| | Gastroenterology | 2 | 2023 | 191 | 0.190 |
Why?
| | Disease Progression | 4 | 2024 | 2864 | 0.190 |
Why?
| | Vital Capacity | 3 | 2024 | 292 | 0.190 |
Why?
| | Hyperplasia | 2 | 2019 | 177 | 0.180 |
Why?
| | Pediatricians | 1 | 2023 | 121 | 0.180 |
Why?
| | Respiratory System Agents | 1 | 2022 | 22 | 0.180 |
Why?
| | Aspergillosis, Allergic Bronchopulmonary | 1 | 2021 | 11 | 0.180 |
Why?
| | Insufflation | 1 | 2021 | 14 | 0.170 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2024 | 237 | 0.170 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 18 | 0.170 |
Why?
| | Medicine | 1 | 2023 | 125 | 0.170 |
Why?
| | Laryngoscopy | 2 | 2020 | 119 | 0.170 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 82 | 0.160 |
Why?
| | Prognosis | 2 | 2024 | 4316 | 0.160 |
Why?
| | Job Satisfaction | 1 | 2023 | 237 | 0.160 |
Why?
| | Spirometry | 1 | 2021 | 233 | 0.160 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2930 | 0.160 |
Why?
| | Surface-Active Agents | 1 | 2021 | 98 | 0.160 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 187 | 0.160 |
Why?
| | Laryngoscopes | 1 | 2020 | 45 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2026 | 981 | 0.150 |
Why?
| | Aminophenols | 1 | 2022 | 202 | 0.150 |
Why?
| | Heart | 1 | 2023 | 626 | 0.150 |
Why?
| | Adult | 6 | 2024 | 40777 | 0.150 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5904 | 0.150 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2019 | 17 | 0.150 |
Why?
| | Digestive System Diseases | 1 | 2019 | 28 | 0.140 |
Why?
| | Ultrasonography | 1 | 2023 | 785 | 0.140 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.140 |
Why?
| | Comorbidity | 2 | 2020 | 1661 | 0.140 |
Why?
| | Consensus | 1 | 2020 | 477 | 0.140 |
Why?
| | Equipment Design | 1 | 2020 | 525 | 0.140 |
Why?
| | Prevalence | 1 | 2025 | 2865 | 0.140 |
Why?
| | Formative Feedback | 1 | 2018 | 36 | 0.130 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.130 |
Why?
| | Bronchiolitis Obliterans | 1 | 2018 | 61 | 0.130 |
Why?
| | Diet | 1 | 2025 | 1277 | 0.130 |
Why?
| | Virtual Reality | 1 | 2019 | 82 | 0.130 |
Why?
| | Biomarkers | 2 | 2019 | 4295 | 0.130 |
Why?
| | Sleep | 1 | 2024 | 888 | 0.120 |
Why?
| | Phenotype | 1 | 2025 | 3155 | 0.120 |
Why?
| | Hospitals, Pediatric | 2 | 2019 | 558 | 0.120 |
Why?
| | Gastrostomy | 1 | 2018 | 130 | 0.120 |
Why?
| | Caregivers | 1 | 2025 | 1073 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 269 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2021 | 547 | 0.120 |
Why?
| | Pediatrics | 1 | 2024 | 1121 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 368 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 303 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1508 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 193 | 0.110 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 35 | 0.110 |
Why?
| | Respiration, Artificial | 1 | 2020 | 713 | 0.110 |
Why?
| | Demography | 1 | 2015 | 282 | 0.110 |
Why?
| | Patient Satisfaction | 2 | 2019 | 709 | 0.110 |
Why?
| | Long-Term Care | 1 | 2015 | 118 | 0.110 |
Why?
| | Anesthesia | 1 | 2018 | 256 | 0.110 |
Why?
| | Larynx | 1 | 2014 | 56 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 583 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 337 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 617 | 0.100 |
Why?
| | Congenital Abnormalities | 1 | 2014 | 109 | 0.100 |
Why?
| | Mutation | 2 | 2022 | 4075 | 0.100 |
Why?
| | Inflammation | 2 | 2022 | 2878 | 0.100 |
Why?
| | United States | 3 | 2023 | 16098 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3413 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2018 | 609 | 0.090 |
Why?
| | Quality of Life | 1 | 2025 | 3204 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1707 | 0.090 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 305 | 0.080 |
Why?
| | Fibrosis | 2 | 2024 | 559 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2134 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 142 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1243 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4553 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 675 | 0.070 |
Why?
| | Esophagus | 2 | 2024 | 262 | 0.070 |
Why?
| | Survival Rate | 1 | 2014 | 2090 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5423 | 0.070 |
Why?
| | Body Mass Index | 1 | 2017 | 2445 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1845 | 0.070 |
Why?
| | Time Factors | 2 | 2019 | 7123 | 0.060 |
Why?
| | Quality Improvement | 1 | 2016 | 1295 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2105 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2021 | 1111 | 0.060 |
Why?
| | Diarrhea | 1 | 2026 | 193 | 0.050 |
Why?
| | Biopsy | 2 | 2019 | 1082 | 0.050 |
Why?
| | Calreticulin | 1 | 2022 | 22 | 0.050 |
Why?
| | HMGB Proteins | 1 | 2022 | 15 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 41 | 0.040 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 90 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2024 | 420 | 0.040 |
Why?
| | Aspergillus fumigatus | 1 | 2021 | 26 | 0.040 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 46 | 0.040 |
Why?
| | Risk Factors | 1 | 2016 | 10885 | 0.040 |
Why?
| | Patient Compliance | 1 | 2025 | 587 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 248 | 0.040 |
Why?
| | Needles | 1 | 2020 | 63 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2020 | 219 | 0.040 |
Why?
| | Quinolones | 1 | 2022 | 203 | 0.040 |
Why?
| | Pressure | 1 | 2020 | 226 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 115 | 0.040 |
Why?
| | Noninvasive Ventilation | 1 | 2020 | 62 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 101 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2025 | 690 | 0.040 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 24 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2019 | 180 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 646 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2021 | 395 | 0.030 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 78 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 371 | 0.030 |
Why?
| | Bronchioles | 1 | 2018 | 29 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2026 | 11772 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 141 | 0.030 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 26 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2023 | 2062 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 574 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 116 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 122 | 0.030 |
Why?
| | Proteome | 1 | 2022 | 514 | 0.030 |
Why?
| | Otolaryngology | 1 | 2019 | 108 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 99 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 707 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 317 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1138 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 231 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 257 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1891 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 391 | 0.030 |
Why?
| | Mouth | 1 | 2015 | 86 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 653 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 943 | 0.030 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 32 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1061 | 0.030 |
Why?
| | Animals | 1 | 2016 | 38030 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2019 | 692 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 130 | 0.020 |
Why?
| | Research Design | 1 | 2019 | 1137 | 0.020 |
Why?
| | Middle Aged | 1 | 2014 | 36215 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 6066 | 0.020 |
Why?
|
|
DeBoer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|